VTP-38543

Vitae Pharmaceuticals, Inc. · Phase 1 active Small molecule

At a glance

Generic name	VTP-38543
Sponsor	Vitae Pharmaceuticals, Inc.
Modality	Small molecule
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

An Ascending Multiple Dose Study of VTP-38543 in Adult Participants With Mild to Moderate Atopic Dermatitis (PHASE1, PHASE2)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

VTP-38543 CI brief — competitive landscape report
VTP-38543 updates RSS · CI watch RSS
Vitae Pharmaceuticals, Inc. portfolio CI